Aslani, Moriba -.
HRN: 21-60-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/12/2023
06/19/2023
PO
7.5ml
TID
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes